Author

A. Zeltins

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Immunology· 3 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 4 Research Focus:host-pathogen & immune response· 3 Assay:proteomics· 2 Organism:E. coli· 1 Organism:human· 1 Organism:mouse· 1 Research Focus:protein folding & dynamics· 1 Research Focus:protein structure prediction· 1

Frequent Co-Authors

G. Resevica· 3 shared I. Balke· 3 shared M. F. Bachmann· 3 shared M. O. Mohsen· 3 shared M. Vogel· 3 shared X. Chang· 3 shared P. S. Krenger· 2 shared A. Manenti· 1 shared

Activity by Year

2020-2023 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 42 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersImmunology

G. Resevica

Mutual co-authors in cluster

Author profile →

4 papers

Recent·Most cited

VPg impact on Ryegrass mottle virus serine-like 3C protease proteolysis and structure

G. Kalnins, R. Ludviga, I. Kalnciema, G. Resevica, V. Zeltina, J. Bogans, K. Tars, A. Zeltins, I. Balke

This paper reports the first full crystal structure of RGMoV Pro with VPg cofactor, identifies a unique interaction site, and confirms a new cleavage site and inhibitory effects of Ca2+ and Zn2+.

bioRxiv · Jan 19, 2023Microbiology

Virus-like particles (VLPs) are efficient tools for boosting mRNA-induced antibodies

A.-C. S. Vogt, L. Jörg, B. Martina, P. S. Krenger, X. Chang, A. Zeltins, M. Vogel, M. O. Mohsen, M. F. Bachmann

This study compares antibody responses from homologous and heterologous prime-boost vaccination strategies using mRNA and VLP-based vaccines against SARS-CoV-2.

bioRxiv · Dec 20, 2021Immunology

Intranasal administration of a VLP-based vaccine against COVID-19 induces neutralizing antibodies against SARS-CoV-2 and Variants of Concerns

D. A. Rothen, P. S. Krenger, A. Nonic, I. Balke, A.-C. Vogt, X. Chang, A. Manenti, F. Vedovi, G. Resevica, S. Walton, A. Zeltins, E. Montomoli, M. Vogel, M. F. Bachmann, M. O. Mohsen

This study evaluates an intranasally administered VLP-based vaccine in a murine model, showing strong systemic and mucosal antibody responses against SARS-CoV-2 and its variants.

bioRxiv · Sep 10, 2021 · PreprintImmunology

The impact of size on particle drainage dynamics and antibody response

S. Zinkhan, A. Ogrina, I. Balke, G. Resevica, A. Zeltins, S. de Brot, C. Lipp, X. Chang, L. Zha, M. Vogel, M. F. Bachmann, M. O. Mohsen

This study compares the draining kinetics and immunogenicity of round and rod-shaped VLPs, finding that round VLPs are more effective in antigen presentation and induce stronger immune responses.

bioRxiv · Sep 28, 2020Immunology